How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...

Nasdaq Dividend History provides straightforward stock’s historical dividends data. Dividend payout record can be used to gauge the company's long-term performance when analyzing individual stocks.

【新智元导读】AI界的「奥本海默时刻」竟是摆拍？Claude Mythos发现0day漏洞的能力过于「夸大了」，不仅有人工掺水，连开源GPT都能轻松踢馆。同时，Opus 4.6正经历最惨的「脑叶切除」。 Claude ...

AI界的「奥本海默时刻」竟是摆拍？Claude Mythos发现0day漏洞的能力过于「夸大了」，不仅有人工掺水，连开源GPT都能轻松踢馆。同时，Opus 4.6正经历最惨的「脑叶切除」。